Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of medicines containing semaglutide following ...
T-cell immunotherapy company Atara Biotherapeutics (Nasdaq: ATRA) closed 41% lower on Friday.
German family-owned pharma major Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical ...
Orna Therapeutics and Shanghai Simnova expand their collaboration to develop RNA-based therapies targeting BCMA for multiple ...
China's National Medical Products Administration (NMPA) has approved the New Drug Application (NDA) of limertinib for the ...
The FDA grants AstraZeneca’s Calquence full approval for first-line mantle cell lymphoma as a combination therapy and ...
Even as the global diabetes war continues to rage, Indian pharmaceutical companies are emerging from the shadows, armed with ...
Despite the strategies and programs that have been implemented to bring effective and equitable access to new medicines and ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today, approved Livdelzi (seladelpar), developed by ...
The neuromuscular disease therapeutics market is projected to grow by $13.7B from 2025 to 2029, driven by advancements in AI, ...
This executive interview, sponsored by BeiGene, is with Jan-Henrik Terwey, Vice President, Medical Affairs Europe at BeiGene.
Servier and Google Cloud expand their partnership to integrate AI and generative AI in drug R&D, focusing on rare diseases.